Drug Manufacture Acumen Pharmaceuticals $130 Million OfferingBy MohamedMis2July 29, 2023 Acumen Pharmaceuticals has recently priced its $130 million offering. Which aims to strengthen the company’s financial position and support its…
Asset Management MorphoSys AG Raises 2022 Revenue GuidanceBy MohamedMis2July 7, 2023 MorphoSys AG, a leading biopharmaceutical company, has announced an upward revision to its guidance for the second quarter and full…
